Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2025-12-25 @ 12:51 PM
NCT ID:
NCT00540995
Group ID:
EG000
Title:
Arm I: 1200cGy
Description:
1200cGy = 150cGy x 8 doses: Patients receive busulfan IV once daily over 2 hours on days -15 and -13 and then every 6 hours on days -12 to -9. Patients also receive etoposide IV on day -3. Patients undergo image-guided intensity-modulated radiation therapy using helical tomotherapy on days -8 to -5.
TRANSPLANTATION: Patients undergo allogeneic peripheral blood stem cell transplantation or bone marrow transplantation on day 0.
GRAFT-VS-HOST DISEASE (GVHD) PROPHYLAXIS: Patients receive GVHD prophylaxis that excludes methotrexate.
busulfan: Given IV
etoposide: Given IV
intensity-modulated radiation therapy: Initially 150 cGy X 8 doses with gradual dose escalation to 200 cGy X 10 doses
allogeneic hematopoietic stem cell transplantation: Stem cell transplantation occurs on Day 0 after High Dose Therapy
allogeneic bone marrow transplantation: Stem cell transplantation occurs on Day 0 after High Dose Therapy
peripheral blood stem cell transplantation: Stem cell transplantation occurs on Day 0 after High Dose Therapy
tomotherapy: Initially 150 cGy X 8 doses with gradual dose escalation to 200 cGy X 10 doses
Deaths Number Affected:
19
Deaths Number At Risk:
None
Serious Number Affected:
7
Serious Number At Risk:
23
Other Number Affected:
23
Other Number At Risk:
23
Study:
NCT00540995
Results Section:
NCT00540995
Adverse Events Module:
NCT00540995